scispace - formally typeset
J

John M. Pezzuto

Researcher at Long Island University

Publications -  599
Citations -  38474

John M. Pezzuto is an academic researcher from Long Island University. The author has contributed to research in topics: Cancer & Resveratrol. The author has an hindex of 88, co-authored 588 publications receiving 35901 citations. Previous affiliations of John M. Pezzuto include Purdue University & Bandung Institute of Technology.

Papers
More filters
Journal ArticleDOI

Cyclooxygenase-inhibitory and antioxidant constituents of the aerial parts of Antirhea acutata.

TL;DR: Two new compounds, (6S)-hydroxy-29-nor-3,4-seco-cycloart-4(30),24-dien-3-oic acid (1) and 8-1-diphenyl-2-picrylhydrazyl free-radical and cytochrome c reduction antioxidant assays (3) were isolated by bioassay-guided fractionation from the aerial parts of Antirhea acutata.
Journal ArticleDOI

Dereplication of Saccharide and Polyol Constituents of Candidate Sweet‐tasting Plants: Isolation of the Sesquiterpene Glycoside Mukurozioside IIb as a Sweet Principle of Sapindus rarak

TL;DR: In this article, gas chromatography-mass spectrometry was used to examine the sugar/polyol content of six sweet-tasting species, comprised of the pericarp of Dialium indum L. (Leguminosae), the stem of Drypetes floribunda Hutchinson (Euphorbiaceae), the fruit of Hymenaea oblongifolia Huber var. (Sapindus rarak DC).
Journal ArticleDOI

Alkyl phenols and derivatives from Tapirira obtusa.

TL;DR: From the bark of Tapiria obtusa, six alkyl phenol derivatives were isolated and (4S*,6S*)-Dihydroxy-6-(14'Z-nonadecenyl)-2-cyclohexenone showed cytotoxic activity.
Journal ArticleDOI

Synthesis of 2-arylindole derivatives and evaluation as nitric oxide synthase and NFκB inhibitors

TL;DR: Synthesis and systematic optimization have been undertaken in an effort to find novel and more potent nitric oxide synthase and NFκB inhibitors with antiinflammatory and cancer preventive potential.
Journal ArticleDOI

Ferrocene incorporated selenoureas as anticancer agents.

TL;DR: The comparative DNA binding studies, antioxidant activities, anti-inflammatory activities, phase II enzyme induction studies (quinone reductase induction) and cytotoxic studies against neuroblastoma, liver cancer, breast cancer and breast cancer of seventeen ferrocene incorporated selenoureas are reported.